Corinne Epperly, M.D.
Board Member
In8bio, Inc. (INAB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Corinne Epperly, M.D.
Corinne Epperly, M.D. is recorded as Board Member at In8bio, Inc. (INAB). In8bio, Inc. reported in an 8-K filed December 7, 2023 that Corinne Epperly, M.D. was appointed Class II director, effective December 6, 2023.
“On December 6, 2023, the Board of Directors (the “Board”) of IN8bio, Inc. (the “Company”) increased the size of the Board from seven to eight directors and, upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Corinne Epperly, M.D., as a Class II director of the Company, with her term expiring at the Company’s 2026 annual meeting of stockholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-12-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at In8bio, Inc.
Other people whose current roles at this company are on record from its filings.
- William Ho CEO, Board Member
- Jeremy Graff Chairman, Board Member
- Patrick McCall CFO
- Kate Rochlin COO
- Kate Rochlin, Ph.D. COO
- Corinne Epperly Board Member
- Emily Fairbairn Board Member
- Jeremy Graff, Ph.D. Board Member
- Luba Greenwood Board Member
- Peter Brandt Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.